Shimla jaundice outbreak
Shimla jaundice outbreak refers to a significant health event that occurred in the city of Shimla, India in 2015-2016. The outbreak was characterized by a sudden increase in the number of cases of jaundice, a disease that causes yellowing of the skin and eyes due to elevated levels of bilirubin in the blood. The outbreak was linked to contamination of the city's water supply with the hepatitis E virus.
Background[edit | edit source]
Shimla is a city in northern India, known for its beautiful landscapes and colonial architecture. However, in late 2015 and early 2016, the city experienced a significant outbreak of jaundice, with thousands of people affected.
Outbreak[edit | edit source]
The outbreak began in December 2015 and continued into early 2016. It was estimated that over 10,000 people were affected by the disease. The cause of the outbreak was traced back to contamination of the city's water supply with the hepatitis E virus. The virus is typically spread through contaminated water or food, and can cause a range of symptoms including jaundice, fatigue, and in severe cases, acute liver failure.
Response[edit | edit source]
The local government, along with health officials, responded to the outbreak by implementing measures to control the spread of the disease. This included treating the water supply to kill the virus, as well as educating the public about the importance of good hygiene practices to prevent further spread of the disease.
Aftermath[edit | edit source]
The outbreak had a significant impact on the city of Shimla, both in terms of the health of its residents and its reputation as a tourist destination. In the aftermath of the outbreak, efforts were made to improve the city's water supply system to prevent similar outbreaks in the future.
See also[edit | edit source]
Shimla jaundice outbreak Resources | ||
---|---|---|
|
|
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD